Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
GOLD Barrick Gold Corp
AMZN Amazon.com Inc
NFLX Netflix Inc
CDTX Cidara Therapeutics Inc
XBTAX BlackRock Long Term Municipal Advantage Trust
PBYA Probility Media Corp
RA Brookfield Real Assets Income Fund Inc.
PAA Plains All American Pipeline LP
$ESDOWD DOW JONES SPAIN STK US$ NDX
Go

Health Care : Biotechnology | Large Cap Growth
Company profile

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

Closing Price
$622.45
Day's Change
13.28 (2.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
630.76
Day's Low
608.76
Volume
(Light)
Volume:
802,497

10-day average volume:
1,152,939
802,497
  • Prev Close
    609.17
  • Today's Open
    612.10
  • Day's Range
    608.76-630.76
  • Avg Vol (10-day)
    1.2M
  • Last (time)
    3:59p ET 07/02/20
  • Last (size)
    2
  • 52-Wk Range
    271.37 - 646.33
    LowHigh
  • (09/27/19 - 06/19/20)
    3.69%
  • 40.8%
  • Market Cap
    63.9B
  • Shares Outstanding
    102.6M
  • 19.90
  • 31.27x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 68.75
  • (% of float 06/15/20)
    2.30

Latest News

July 02, 2020
10:47 pm ET
PR Newswire
4:59 pm ET
MarketWatch
4:29 pm ET
PR Newswire
July 01, 2020
11:28 am ET
Globe Newswire
June 24, 2020
3:23 pm ET
PR Newswire
June 22, 2020
8:34 am ET
Zacks
June 15, 2020
7:37 am ET
MarketWatch
June 11, 2020
7:26 am ET
MarketWatch
12:59 am ET
PR Newswire
June 10, 2020
9:00 am ET
PR Newswire
June 08, 2020
9:00 am ET
PR Newswire
June 06, 2020
12:04 pm ET
MarketWatch
June 05, 2020
7:00 am ET
PR Newswire
June 01, 2020
7:57 am ET
MarketWatch
6:43 am ET
MarketWatch
May 29, 2020
4:01 pm ET
PR Newswire
10:40 am ET
Zacks
8:00 am ET
PR Newswire
May 26, 2020
7:55 pm ET
PR Newswire
11:39 am ET
PR Newswire
8:44 am ET
MarketWatch
May 25, 2020
12:40 pm ET
PR Newswire
6:31 am ET
Globe Newswire
May 22, 2020
6:47 pm ET
PR Newswire
May 20, 2020
9:16 am ET
PR Newswire
May 16, 2020
12:02 pm ET
MarketWatch
May 13, 2020
5:00 pm ET
PR Newswire
May 11, 2020
7:00 am ET
PR Newswire
May 09, 2020
2:19 pm ET
MarketWatch
May 08, 2020
2:46 pm ET
MarketWatch
May 07, 2020
12:35 pm ET
MarketWatch
May 05, 2020
6:44 am ET
MarketWatch
6:33 am ET
MarketWatch
6:32 am ET
MarketWatch
6:32 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.